Author:
Moorcraft Sing Yu,Marriott Cheryl,Peckitt Clare,Cunningham David,Chau Ian,Starling Naureen,Watkins David,Rao Sheela
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference43 articles.
1. Schroen AT, Petroni GR, Wang H, Gray R, Wang XF, Cronin W, et al. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials. Clin Trials. 2010;7(4):312–21. doi: 10.1177/1740774510374973 .
2. Schroen AT, Petroni GR, Wang H, Thielen MJ, Gray R, Benedetti J, et al. Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups. Clin Cancer Res. 2012;18(1):256–62. doi: 10.1158/1078-0432.CCR-11-1633 .
3. Stensland K, McBride R, Wisnivesky J, Asma Latif A, Hendricks R, Roper N, et al. Premature termination of genitourinary cancer clinical trials. J Clin Oncol. 2014;32 Suppl 4:abstr 288).
4. National Institute for Health Research. Performance in Initiating and Delivering Research. 2015 http://www.nihr.ac.uk/policy-and-standards/Performance-in-initiating-anddelivering-research.htm . Accessed on 08.01.16.
5. Cancer Research UK. Our research on clinical trials and new treatments. 2014. http://www.cancerresearchuk.org/our-research/our-research-by-cancersubject/our-research-on-clinical-trials-and-new-treatments . Accessed on 08.01.16.
Cited by
146 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献